Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Appointment of two highly respected sector leaders reflects a strong belief in the strategic and commercial value of the company’s technology and reinforces its ability to accelerate its path to marketGhent, BELGIUM, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Press Release Biotalys (Euronext Brussels: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announced the appointment of Christine Berwaerts and Ioana Tudor to i
Approval in one of the world's most stringent regulatory jurisdictions and important crop protection markets provides important regulatory precedent for Biotalys’ AGROBODY® biocontrolsGhent, BELGIUM, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Press Release Biotalys (Euronext Brussels: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announced that the California Department of Pesticide Regulation (CDPR) has granted st
Company Provides R&D UpdateGhent, BELGIUM, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Press release – regulated information Made substantial regulatory progress in both the U.S. and E.U. with first protein-based biocontrol EVOCA®, paving the regulatory pathway for its commercial version EVOCA NG Achieved promising results in field trials with a second lead BioFun-6 candidate from the AGROBODY® technology platform Entered into a strategic partnership with 21st.BIO, a leading precision fermentation technol
Webcast and Conference Call to take place on Thursday, 20 August 2026 at 15:00 CET / 14:00 GMT / 09:00 AM ETGhent, BELGIUM, July 06, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces that it will publish its financial results and business highlights for the first half of 2026 on Thursday, 20 August 2026 at 07:00 CEST. Webcast and Conference C
State authority initiates public commenting phase following positive human health assessment, marking key step toward potential state registrationGhent, BELGIUM, July 01, 2026 (GLOBE NEWSWIRE) -- Press Release Biotalys (Euronext Brussels: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces further progress in the regulatory review process of its first biofungicide, EVOCA®, in the United States. The Cali
Ghent, BELGIUM, June 30, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext: BTLS) an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announced that Patick Van Beneden will retire from Biotalys’ Board of Directors, effective 30 June 2026. Patrick Van Beneden has served as a non-executive director of Biotalys since its founding in 2013. He gained extensive experience in Life Sciences and AgTech through his career
Regulated informationGhent, BELGIUM, May 29, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext - BTLS) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, held its ordinary shareholders' meeting today at 10:00 CEST at the Company’s seat. The shareholders approved all items on the agenda of the meetings. All documents relating to the shareholders’ meetings can be consulted on the website of the Co
Regulated informationGhent, BELGIUM, May 28, 2026 (GLOBE NEWSWIRE) -- Press release Publication of transparency notifications(Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated market) Biotalys NV (Euronext Brussel : BTLS) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, announces today, in accordance w
Regulated information on the total number of voting rights and sharesGhent, BELGIUM, May 20, 2026 (GLOBE NEWSWIRE) -- Press releae - regulated information Biotalys NV (Euronext Brussel : BTLS) (the “Company” or “Biotalys”), today announced the closing of its previously announced private placement of 7,875,811 new shares (being approximately 20.96% of the Company’s shares outstanding prior to the transaction) at an issue price of EUR 1.53 per share. The new shares will be listed on Euronext Bruss
Press release – regulated information – inside informationGhent, BELGIUM, May 06, 2026 (GLOBE NEWSWIRE) -- Public announcement in accordance with article 7:97,§4/1 of the Belgian Companies and Associations Code Biotalys (Euronext: BTLS) (the “Company” or “Biotalys”), today announced it has successfully obtained subscription commitments for new shares for an amount of EUR 12,050,000 through a private placement (“Private Placement”). The Private Placement involves the issue of 7,875,811 new shares
Regulated informationGhent, BELGIUM, April 29, 2026 (GLOBE NEWSWIRE) -- Earned final approval by the U.S. EPA and positive recommendation by the Dutch regulator for its first candidate biofungicide EVOCA™, paving the path for its commercial version EVOCA NG Streamlined leadership and operations to concentrate resources on commercial preparation of EVOCA NG and BioFun-6 in high-value markets Year-end cash and cash equivalents amounted to €8.0 million, providing a financial runway until end of May
Regulatory Process also Advancing in Key Markets California and EuropeGhent, BELGIUM, April 27, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced that its innovative biofungicide EVOCA™ has achieved state registration in Florida. This marks the first approval of an AGROBODY™ biocontrol by a U.S. state, underscoring a significant milestone for the compa
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.